Cormark Has Bullish Estimate for kneat.com FY2024 Earnings

kneat.com, inc. (TSE:KSI) – Analysts at Cormark boosted their FY2024 EPS estimates for kneat.com in a note issued to investors on Thursday, November 7th. Cormark analyst G. Fairweather now anticipates that the company will post earnings per share of ($0.08) for the year, up from their previous forecast of ($0.12). The consensus estimate for kneat.com’s current full-year earnings is ($0.12) per share. Cormark also issued estimates for kneat.com’s FY2025 earnings at ($0.02) EPS and FY2026 earnings at $0.03 EPS.

KSI has been the subject of a number of other reports. CIBC set a C$6.00 price target on kneat.com and gave the stock an “outperform” rating in a research note on Tuesday, October 29th. Ventum Cap Mkts raised shares of kneat.com to a “strong-buy” rating in a research report on Wednesday, August 7th. Finally, Cibc World Mkts upgraded shares of kneat.com to a “strong-buy” rating in a research note on Tuesday, October 29th.

kneat.com Price Performance

Shares of TSE:KSI opened at C$5.05 on Monday. The business has a fifty day simple moving average of C$4.76 and a 200 day simple moving average of C$4.50. The company has a current ratio of 1.47, a quick ratio of 1.50 and a debt-to-equity ratio of 95.14. kneat.com has a 1 year low of C$2.73 and a 1 year high of C$5.17. The firm has a market cap of C$434.30 million, a price-to-earnings ratio of -31.56, a P/E/G ratio of 597.67 and a beta of 1.08.

About kneat.com

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.